Vitamin K-2 Menaquinone-7 50 mcg

product on market Capsule Solaray 🟢 Safety: 100/100
Brand: Solaray
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 VegCap(s) Serving Size
60 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

50 mcg
✅ Within RDA (0.4× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.05mg

Other Ingredients

Cellulose Cellulose Glycerol Monostearate Magnesium Stearate fermented defatted Chickpea flour extract Rice Extract Blend Silica

Label Claims — Verification

❓ Nutrient
❓ All Other
❓ Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Dairy Free

Product Information

📋 Directions for Use

Directions: Use only as directed. Take 1 VegCap daily with a meal or glass of water.

⚠️ Warnings & Precautions

Warning: Do not use if safety seal is broken or missing. Keep your licensed health care practitioner informed when using this product.

Keep out of reach of children.

🧪 Formulation Notes

Bone support Arterial support

Vegan

Discussion: The premium Vitamin K-2 menaquinone-7 used in this formula is derived from chickpea. Menaquinone-7 (MK-7) is known to have a longer half-life than other forms of Vitamin K, and is therefore believed to offer unique benefits to the body. It helps support cardiovascular health, bone formation and vascular health.

Additional Information

Lab Verified Vegan

Since 1973, we've scoured the globe for the highest quality ingredients, connecting you with the most efficacious supplements that help you live brighter & embrace the moments that matter most.

Store in a cool, dry place.

100% PCR Bottles

Product Details

UPC / SKU 0 76280 87496 9
DSLD Entry Date 2025-03-25
Product Type Vitamin
Form Capsule
Brand Solaray
DSLD ID 326154
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI
View all evidence for Vitamin K →

Compare Similar Products

Vitamin D Synergy with Vitamin K1
Vitamin D Synergy with Vitamin K1 Designs for Health 100
Vitamin D Synergy with Vitamin K1
Vitamin D Synergy with Vitamin K1 Designs for Health 100
Natural Vitamin K2 45 mcg
Natural Vitamin K2 45 mcg Doctor's Best 100
K 100 mcg
K 100 mcg Thompson 100
Vitamin K2 300 mcg MK-7
Vitamin K2 300 mcg MK-7 Innerzyme 100
View all Vitamin K products →
Vitamin K research & evidence Best Vitamin K rankings All Vitamin K products More from Solaray View on NIH DSLD →